Alambic Investment Management’s VYNE Therapeutics VYNE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q4 | – | Sell |
-211
| Closed | -$25K | – | 45 |
|
|
2020
Q3 | $25K | Buy |
+211
| New | +$25K | 0.27% | 69 |
|
|
2020
Q1 | – | Sell |
-748
| Closed | -$250K | – | 278 |
|
|
2019
Q4 | $250K | Buy |
748
+176
| +31% | +$58.8K | 0.21% | 183 |
|
|
2019
Q3 | $185K | Buy |
572
+353
| +161% | +$114K | 0.14% | 221 |
|
|
2019
Q2 | $94K | Sell |
219
-712
| -76% | -$306K | 0.06% | 272 |
|
|
2019
Q1 | $526K | Sell |
931
-1,464
| -61% | -$827K | 0.22% | 166 |
|
|
2018
Q4 | $710K | Buy |
+2,395
| New | +$710K | 0.3% | 123 |
|